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Objectives: The aim of this study is to evaluate the ability and practice of spirometry, training 
of technicians, and spirometry features in primary care centers in Spain, evaluating those located 
in a rural environment against those in urban areas.
Methods: An observational cross-sectional study was conducted in 2012 by a telephone survey 
in 970 primary health care centers in Spain. The centers were divided into rural or urban depend-
ing on the catchment population. The survey contacted technicians in charge of spirometry and 
consisted of 36 questions related to the test that included the following topics: center resources, 
training doctors and technicians, using the spirometer, bronchodilator test, and the availability 
of spirometry and maintenance.
Results: Although the sample size was achieved in both settings, rural centers (RCs) gave a lower 
response rate than urban centers (UCs). The number of centers without spirometry in rural areas 
doubled those in the urban areas. Most centers had between one and two spirometers. However, 
the number of spirometry tests per week was significantly lower in RCs than in UCs (4 [4.1%] 
vs 6.9 [5.7%], P,0.01). The availability of a specific schedule for conducting spirometries was 
higher in RCs than in UCs (209 [73.0%] vs 207 [64.2%], P=0.003). RCs were more satisfied 
with the spirometries (7.8 vs 7.6, P=0.019) and received more training course for interpreting 
spirometry (41.0% vs 33.2%, P=0.004). The performance of the bronchodilator test showed a 
homogeneous measure in different ways. The spirometer type and the reference values were 
unknown to the majority of respondents.
Conclusion: This study shows the differences between primary care RCs and UCs in Spain in 
terms of performing spirometry. The findings in the present study can be used to improve the 
performance of spirometry in these areas.
Keywords: respiratory functional test, rural health, obstructive lung diseases
Introduction
Rural and urban communities have distinct characteristics in terms of demographics, 
social, and physical environments and may vary in access to health care facilities and 
services. The characteristics of rural patients have been studied in some communities 
showing sociodemographic differences.1 Additionally, important differences have 
been reported in different respiratory conditions in different countries between rural 
and urban areas from a epidemiological and clinical standpoint.2,3 Of note, disparities 
in pulmonary function have also been reported.4 Examination of geographic variation 
in disease occurrence and other disease measures provides a method for detection of 
gaps in quality of public health activities and clinical health care services.5
Spirometry is a necessary diagnostic technique for the diagnosis of many preva-
lent chronic respiratory diseases. In fact, spirometry is the most used guidelines for 
diagnosis and treatment of chronic obstructive pulmonary disease (COPD) as the Global 
Initiative for Chronic Obstructive Lung Disease indicates that it is a prerequisite for 
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diagnosing the disease and a necessary tool to establish the 
best treatment possible.6 The Global Initiative for Asthma 
(GINA) recommends spirometry to measure airflow limita-
tion, and its reversibility highlights and confirms the diag-
nosis of asthma.7
In Spain, a recent study was done comparing the use of 
spirometry in primary and secondary care (3E project).8 The 
study showed important differences in the use, training, and 
maintenance of spirometers. By using the 3E database, the 
aim of the study was to evaluate the ability and practice of 
spirometry, training of technicians, and spirometry features 
in primary care centers in Spain, evaluating those located in 
a rural environment against those in urban areas.
Methods
This study is a subanalysis of the 3E project, whose method-
ology is available elsewhere.8 In short, it is a cross-sectional 
study of 970 primary care centers in Spain that routinely eval-
uated adult patients with respiratory disease. The question-
naire consisted of 36 items that included the following topics: 
center resources, training doctors and technicians, using the 
spirometer, bronchodilator test (BDT), and the availability 
of spirometry and maintenance. The survey was conducted 
between January 2012 and March 2012 by telephone, through 
a semi-structured computer-assisted telephone interview done 
to the technicians responsible for performing the spirometries 
with an average of 20 minutes duration.
The aim of this study was to obtain information from 
20% of the primary care centers in Spain. The centers 
were divided in rural or urban depending on the catchment 
population (25,000 habitants was considered the limit). The 
present study did not involve human subjects, material, or 
data, so an ethics committee approval was deemed not to 
be necessary. All participants gave oral consent to complete 
the survey.
Data analysis was performed using the Statistical Pack-
age for the Social Sciences software version 18.0 (IBM 
Corporation, Armonk, NY, USA). Description of variables 
was done using the absolute and relative frequencies for 
categorical responses. Inferential studies were conducted 
comparing data from rural centers (RCs) to urban centers 
(UCs) using chi-square test and Student’s t-test for inde-
pendent data. A P-value lower than 0.05 was considered 
statistically significant.
Results
To survey 20% of primary care centers in Spain, 970 centers 
were screened (43.9% RCs and 56.6% UCs). Data were 
obtained from 21.2% of those in Spain. The response rate 
was 51.5% for RCs and 76.4% for UCs (P,0.001). Of 
these 266 RCs that were not surveyed, 38.7% did not have 
spirometer, 20.7% did have a spirometer but were not using 
it, and 40.6% declined participation. In the 99 UCs that 
were not surveyed, 46.5% did not have spirometer, 19.2% 
did have a spirometer but were not using it, and 34.3% 
refused participation (Figure 1). Accordingly, the number 
of centers without spirometry in rural areas doubled the 
urban areas.
In most primary care centers, spirometry was performed 
only in the center, 264 (94.0%) of RCs and 313 (97.2%) of UCs. 
Most centers, both UCs and RCs, had between one and two 
spirometers (Table 1). However, the number of spirometry 
tests per week was significantly lower in RCs than in UCs 
(P,0.001). Among major needs for the performance and 
interpretation were to have more training (20.5% of UCs 
and 15.9% of RCs) and adequate room (11.0% of RCs and 
14.6% of UCs), while major needs for the interpretation of 
spirometry were being properly trained (15.8% of UCs and 
17.0% of RCs), followed by having staff who can interpret 
them (4.7% of UCs and 4.2% of RCs). The availability of 
a specific schedule for conducting spirometries in absolute 
numbers is very close but in percentage was higher in RCs 
than in UCs (P=0.003).
Staff and training outcomes are summarized in Table 2. 
Nurses were the main professional who did spirometries both in 
RCs and UCs, but mostly in UCs (P=0.005). Most centers had 
received some training for performing spirometry. In most cen-
ters, this training was both theoretical and practical, but usually 
at only one point with a mean of 22.5 months from the last train-
ing in RCs and 18.5 months in UCs, without training further 
repeated. RCs were more satisfied with the spirometries (7.8 vs 
7.6, P=0.019) and passed more training course for interpreting 
spirometry (41.0% vs 33.2%, P=0.004).
Regarding using the spirometer (Table 3), the majority 
of the indications were to the study of asthma or COPD, 
with an estimated number of spirometry considered invalid 
approximately 10%.
The realization of the BDT (Table 4) was performed 
homogeneously, which is demonstrated by analyzing different 
points. According to current recommendations,9 an improve-
ment in either forced vital capacity (FVC) or forced expiratory 
volume in 1 second (FEV
1
) was considered reversible. Most 
centers used short-acting β
2
 agonists for BDT, but in general, 
the number of inhalations was often insufficient and time to 
wait was often incorrect. The criteria for considering a positive 
BDT were right in almost half of the respondents.
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The spirometer type and the reference values were 
unknown to the majority of responding technicians (Table 5); 
UCs used values of the Spanish Society and RCs had a greater 
ignorance of the values used.
Finally, information on the maintenance of the spirom-
eter is summarized in Table 6. Not all centers calibrated the 
spirometer daily. When asked for the reason of not cali-
brating, the most common response was nonavailability of 
syringe calibration or nonrequirement by the device.
Discussion
The study of 3E project highlights the differences between 
primary care UCs and RCs in Spain in terms of scope of 
practice of spirometry. The principal findings are differ-
ences in the number of spirometry performed and specific 
planning, which is higher in UCs than in RCs; satisfaction 
with the performance of spirometry and the number of centers 
receiving courses for interpretation, which is higher in RCs 
than UCs; and the use and knowledge of the reference values, 
which is higher in UCs than in RCs.
This is the first survey that was published in Spain with 
national coverage, whose results were partially published 
previously.10,11 The most important strength of our study is the 
analysis of the rural and urban population in terms of perform-
ing spirometry, something that had not been described previ-
ously. The main contribution of this study is the large sample 
size, with a representation of the entire national territory and 
a protocol applied evenly. However, there are a number of 
limitations that should be considered. The first one is that 
the survey was conducted to the technician who did the test. 
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Figure 1 Flowchart of the centers surveyed.
Table 1 Information on center resources
Urban (n=322) Rural (n=283) P-value*
number of spirometers per center 1.17 (0.4) 1.11 (0.3) 0.080
spirometry done only in that center (%) 313 (97.2) 264 (94.0) 0.022
spirometry done in different centers with portable spirometer (%) 3 (0.9) 8 (1.3) 0.08
spirometry done in different centers with the spirometer of the center (%) 6 (1.9) 9 (3.2) 0.29
average number of spirometries conducted per week 6.9 (5.7) 4.0 (4.1) ,0.001
Centers with no perceived needs regarding the performance of spirometry (%) 122 (37.9) 127 (44.9) 0.083
Centers with no perceived needs regarding interpretation (%) 218 (67.7) 203 (71.7) 0.289
Centers with specific time and schedule (%) 207 (64.2) 209 (73.9) 0.003
Centers with allocated room (%) 219 (68.2) 176 (62.2) 0.124
Notes: *P-values between rural and urban centers are calculated by unpaired student’s t-test or χ2 test as appropriate. Data are expressed as mean (standard deviation) or 
absolute (relative) frequencies (%). Bold numbers mean significant statistical differences.
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Table 2 Information regarding staff and training
Urban (n=322) Rural (n=283) P-value*
Centers with spirometries done by a nurse (%) 320 (99.4) 271 (95.8) 0.005
Centers that received any training course for conducting spirometry (%) 268 (83.2) 243 (85.9) 0.431
Type of spirometry training course received
Theoretical and practical 207 (64.3) 201 (71.0) 0.204
Only theoretical 44 (13.7) 30 (10.6) 0.286
Only practical 57 (17.7) 38 (13.4) 0.176
level of satisfaction with your own training (1–10)† 7.04 (1.6) 7.06 (1.7) 0.845
Centers’ interpretation done by a general practitioner (%) 316 (98.1) 272 (96.1) 0.146
level of satisfaction with spirometries (1–10)† 7.6 (1.3) 7.8 (1.1) 0.019
Centers that received any training course for interpretation (%) 107 (33.2) 116 (41.0) 0.004
Notes: *P-values between rural and urban centers are calculated by unpaired student’s t-test or χ2 test as appropriate. Data are expressed as mean (standard deviation) or 
absolute (relative) frequencies (%). †Level of satisfaction was evaluated using a scale from 1 (lowest satisfaction) to 10 (highest satisfaction). Bold numbers mean significant 
statistical differences.
Table 3 Information regarding spirometer use
Urban (n=322) Rural (n=283) P-value*
estimation of percentage of spirometries not valid (%) as judged by the technician 
surveyed
9.7 (10.8) 9.8 (10.6) 0.994
any previous information given to the patient (%) 282 (87.6) 246 (86.9) 0.886
Main indications
asthma (%) 33.9 (19.5) 31.7 (19.6) 0.201
COPD (%) 47.8 (20.4) 51.6 (23.7) 0.046
Other respiratory diseases (%) 10.6 (14.4) 9.4 (14.7) 0.314
Notes: *P-values between rural and urban centers are calculated by unpaired student’s t-test or χ2 test as appropriate. Data are expressed as absolute (relative) frequencies (%). 
Bold numbers mean significant statistical differences.
Abbreviation: COPD, chronic obstructive pulmonary disease. 
Table 4 Information regarding the bronchodilator test
Urban (n=322) Rural (n=283) P-value*
Indication to suspend inhalers before spirometry
always (%) 297 (92.2) 260 (91.9) 0.881
Occasionally (%) 12 (3.7) 8 (2.8) 0.651
never (%) 13 (4.0) 15 (5.3) 0.562
Percentage of patients’ test not done for not having withdrawn inhalers (%) 6.6 (12.9) 4.9 (7.9) 0.053
Which drugs do you have available for the bronchodilator test
salbutamol (%) 299 (92.9) 270 (95.4) 0.228
Terbutaline (%) 24 (7.5) 31 (11.0) 0.157
Ipratropium (%) 12 (3.7) 22 (7.8) 0.034
Which one of them do you normally use?
salbutamol (%) 296 (94.3) 265 (96.4) 0.251
Terbutaline (%) 15 (4.8) 7 (2.5) 0.193
Ipratropium (%) 3 (1.0) 3 (1.1) 1.000
how many inhalations you give?
salbutamol 2.6 (0.8) 2.6 (0.8) 0.784
Terbutaline 2.3 (0.6) 2.1 (0.6) 0.200
Ipratropium 2.3 (0.7) 2.1 (0.4) 0.209
how long do you wait for the second spirometry?
10 min (%) 59 (19) 50 (18.3) 0.915
15 min (%) 149 (47.9) 117 (42.9) 0.244
20 min (%) 84 (27.0) 86 (31.5) 0.237
30 min (%) 12 (3.9) 11 (4.0) 1.000
Criterion to consider a positive bronchodilator test is increasing 12% and 200 ml (%) 117 (58.5) 74 (52.1) 0.270
Notes: *P-values between rural and urban centers are calculated by unpaired student’s t-test or χ2 test as appropriate. Data are expressed as mean (standard deviation) or 
absolute (relative) frequencies (%). Bold numbers mean significant statistical differences.
Abbreviation: min, minutes. 
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Table 5 Information regarding spirometer features
Urban  
(n=322)
Rural  
(n=283)
P-value*
Type of transducer
Pneumotachometer (%) 52 (16.1) 39 (13.8) 0.428
Turbine (%) 119 (37.0) 106 (37.5) 0.933
Curves only on the screen (%) 299 (92.9) 258 (91.2) 0.455
reference values
sePar (%) 124 (38.5) 83 (29.3) 0.020
ers (%) 5 (1.6) 1 (0.4) 0.222
Do not know/answer (%) 190 (59.0) 196 (69.3) 0.011
Notes: *P-values between rural and urban centers are calculated by unpaired 
student’s t-test or χ2 test as appropriate. Data are expressed as absolute (relative) 
frequencies (%). Bold numbers mean significant statistical differences.
Abbreviations: sePar, sociedad española de neumología y Cirugía Torácica; ers, 
european respiratory society.
Table 6 Information regarding spirometer maintenance
Urban (n=322) Rural (n=283) P-value*
Meteorological information
automatically provided by the device (%) 153 (50.3) 121 (45.7) 0.275
Meteorological station in the room (%) 97 (31.9) 94 (35.5) 0.375
how often do you calibrate the spirometer?
every day it is used (%) 119 (37.0) 115 (40.6) 0.551
never (%) 32 (9.9) 26 (9.2) 0.909
reasons for not never calibrating
Do not have the calibrating syringe (%) 8 (25.0) 10 (38.0) 0.393
The device does not require it (%) 8 (25.0) 6 (23.1) 0.946
There is a person in charge of the maintenance (%) 186 (57.8) 179 (63.3) 0.281
how often do you do maintenance?
More than once a day (%) 56 (17.4) 59 (20.8) 0.469
Once a month (%) 60 (18.6) 59 (20.8) 0.631
Use a different filter for every patient (%) 257 (79.8) 229 (80.9) 0.909
Notes: *P-values between rural and urban centers are calculated by unpaired student’s t-test or χ2 test as appropriate. Data are expressed as absolute (relative) frequencies (%).
This way of performing the survey are beneficial in that the 
questions are to the person that daily performed the test, 
although when assessing questions about the interpretation of 
results have to be cautious. Additionally, the work has been 
done through a telephone survey, which has the advantages 
of access to centers with less resource, be faster than the 
mail or personal interviews, and to survey a large number of 
centers but always carries some degree of non-response and 
make necessary to confirm the veracity of what the respon-
dent answered. Survey was self-reported, in which remained 
external validity. But because the response rate was high, we 
trusted the validity and representativeness of the data obtained. 
Finally, in order to encourage participation, we deliberately 
limited the number of questions to those which we thought 
were most relevant. It is then possible that some relevant 
aspects of spirometry may have been left out. In particular, 
the quality criteria to consider a valid spirometry were not 
included in the survey. In addition, one interesting approach 
for the future would be to correlate our findings with the 
clinical management of the patients in order to evaluate if 
performing a correct spirometry may have some influence on 
clinical care provided to patients or on clinical outcomes.
Spirometry is an essential technique for the diagnosis of 
prevalent diseases such as asthma or COPD. However, its 
use in primary care centers is not widely achieved. In Spain, 
only half of the patients diagnosed with COPD in primary 
care had a spirometry,12 which has also been identified in 
other countries like the USA in studies with more than 
90,000 patients.13 People with unrecognized COPD may 
miss the opportunity to improve their health status because 
of lack of performance of functional tests.14 The evaluation 
of the variability among rural and urban regions is essential 
in order to explore the situation in Spain. This variability in 
primary care has also been described within other countries. 
In Italy, a study conducted on 617,280 patients revealed 
that treatment was usually prescribed without performing 
pulmonary function tests or without taking into account the 
severity of airway obstruction.15 Importantly, COPD patients 
in rural areas have been associated with worse health status 
and greater impairment.16 There is little information in Spain 
to analyze the characteristics of the population using these 
services. In order to make informed decisions about the 
allocation of resources, it seems important to know more 
information on these patients than the number of patients 
who have undergone spirometry.
One of the most important points of our study is the find-
ing of the low number of spirometry tests that are done in 
the primary care centers in Spain. Differences between UCs 
and RCs are shown both in spirometry number and program-
ming the time and schedule. Rural and urban communities 
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have distinct characteristics in terms of demographic, 
social, and physical environments and may vary in access 
to health care facilities and services. Some studies have 
shown that in certain areas such as in Canada, rural residents 
tend to be older and are more likely to be obese, have less 
education, and have lower income than urban residents.17 
Rural populations also have a higher prevalence of chronic 
conditions such as diabetes and heart disease.18 End-of-
life decisions in COPD are also different in rural areas in 
Spain.19 However, rural residents report several barriers to 
accessing health care, including transportation difficulties 
and distance to care, social isolation, financial constraints, 
limited health care facilities (hospitals and pharmacies), 
physician shortages, and lack of access to specialist care. 
The lack of access to primary care physicians, specialists, 
or health care facilities could result in decreased prescrib-
ing of evidence-based medications. In fact, in a sample of 
COPD patients in the USA, it was found that rural residents 
were associated with poorer health status and higher levels 
of utilization of selected health care services compared to 
urban residents.16 Because rural communities have a higher 
proportion of older residents, there is a higher demand of 
health care services for chronic conditions; hence, the ser-
vices provided should be better.
Another important finding in this study is the difference 
found in the degree of satisfaction with spirometry and the 
number of centers that perform training courses for interpreta-
tion of spirometry. Training is surprisingly higher in RCs than 
in UCs. Spirometry is not an extremely difficult technique 
to perform but requires learning, and this is maintained over 
time. This is what the European Respiratory Society aimed 
with the dissemination of a spirometry training program 
within Europe.20 Educational program had a very limited 
impact on general practitioners’ clinical practice. The usage 
of spirometry is poor with the general practitioners tending to 
perform more chest X-rays than pulmonary function tests.21 
In our study, it appears that the satisfaction and the amount 
of training is higher in RCs than in UCs.
The usefulness of the BDT in the diagnosis and treatment 
of asthma and COPD has been and continues to be a source of 
debate. Despite its simplicity, it remains difficult to interpret 
and translate into specific therapeutic strategies, particularly 
in COPD.22 In our study, it seems that there are few differ-
ences between the UCs and RCs. As for the bronchodilator 
used, we enquired on the most commonly used. However, 
it is possible that some centers used more than one, but the 
survey did not ask for this possibility and the respondents 
were forced to choose one.
Calibration is absolutely necessary, this being one of the 
weaknesses we have observed with our work. In our study, we 
found no differences in calibration, but it stresses that not all 
centers’ spirometers calibrated daily. We believe that these 
data should be assessed and encourage health authorities to 
take the necessary measures to resolve this problem that can 
cause problems in diagnosis.
In summary, this study shows the differences between 
primary care RCs and UCs in Spain in terms of performing 
spirometry. In RCs, less spirometries are performed, but the 
degree of satisfaction and the number of training sessions are 
greater in UCs. These findings can be used to improve and 
standardize health care resources to ensure similar cover-
age to the entire population, regardless of the area in which 
resides.
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